Risperdal settlement to cost J&J $181 millionRisperdal to providers treating patients with Alzheimer's and dementia, Reuters reported. The drug, which is intended to treat schizophrenia, is not approved for these conditions.
Eighty-two percent of senior living providers see a shortage of workers as a key concern over the next year, according to a new survey from Lancaster Pollard.
Atrium Health, formerly known as Carolinas HealthCare System, and Navicent Health, have signed a Letter of Intent to combine forces.
Kwalu and THW Design have partnered to create a new and upscale furniture collection for seniors housing.